|
1
|
Siegel RL, Giaquinto AN and Jemal A:
Cancer statistics, 2024. CA Cancer J Clin. 74:12–49. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kreier F: Cancer will cost the world $25
trillion over next 30 years. Nature. Mar 7–2023.(Epub ahead of
print). doi: 10.1038/d41586-023-00634-9. View Article : Google Scholar
|
|
3
|
Hanahan D: Rethinking the war on cancer.
Lancet. 383:558–563. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee JH and Wee CW: Treatment of Adult
Gliomas: A current update. Brain Neurorehabil. 15:e242022.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee SH, Hu W, Matulay JT, Silva MV,
Owczarek TB, Kim K, Chua CW, Barlow LJ, Kandoth C, Williams AB, et
al: Tumor evolution and drug response in patient-derived organoid
models of bladder cancer. Cell. 173:515–528.e17. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Boustani J, Grapin M, Laurent PA, Apetoh L
and Mirjolet C: The 6th R of radiobiology: Reactivation of
anti-tumor immune response. Cancers (Basel). 11:8602019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Barazzuol L, Coppes RP and van Luijk P:
Prevention and treatment of radiotherapy-induced side effects. Mol
Oncol. 14:1538–1554. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Strong MJ, Baddoo M, Nanbo A, Xu M,
Puetter A and Lin Z: Comprehensive high-throughput RNA sequencing
analysis reveals contamination of multiple nasopharyngeal carcinoma
cell lines with HeLa cell genomes. J Virol. 88:10696–10704. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nagle PW and Coppes RP: Current and future
perspectives of the use of organoids in radiobiology. Cells.
9:26492020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Stewart-Ornstein J, Iwamoto Y, Miller MA,
Prytyskach MA, Ferretti S, Holzer P, Kallen J, Furet P, Jambhekar
A, Forrester WC, et al: p53 dynamics vary between tissues and are
linked with radiation sensitivity. Nat Commun. 12:8982021.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hammond EM and Muschel RJ: Radiation and
ATM inhibition: The heart of the matter. J Clin Invest.
124:3289–3291. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu SJ, Malatesta M, Lien BV, Saha P,
Thombare SS, Hong SJ, Pedraza L, Koontz M, Seo K, Horlbeck MA, et
al: CRISPRi-based radiation modifier screen identifies long
non-coding RNA therapeutic targets in glioma. Genome Biol.
21:832020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fujii M, Shimokawa M, Date S, Takano A,
Matano M, Nanki K, Ohta Y, Toshimitsu K, Nakazato Y, Kawasaki K, et
al: A colorectal tumor organoid library demonstrates progressive
loss of niche factor requirements during tumorigenesis. Cell Stem
Cell. 18:827–838. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Boj SF, Hwang CI, Baker LA, Chio II, Engle
DD, Corbo V, Jager M, Ponz-Sarvise M, Tiriac H, Spector MS, et al:
Organoid models of human and mouse ductal pancreatic cancer. Cell.
160:324–338. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kang Y, Zhou Y, Li Y, Han Y, Xu J, Niu W,
Li Z, Liu S, Feng H, Huang W, et al: A human forebrain organoid
model of fragile X syndrome exhibits altered neurogenesis and
highlights new treatment strategies. Nat Neurosci. 24:1377–1391.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gao D, Vela I, Sboner A, Iaquinta PJ,
Karthaus WR, Gopalan A, Dowling C, Wanjala JN, Undvall EA, Arora
VK, et al: Organoid cultures derived from patients with advanced
prostate cancer. Cell. 159:176–187. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
de Boo J and Hendriksen C: Reduction
strategies in animal research: A review of scientific approaches at
the intra-experimental, supra-experimental and extra-experimental
levels. Altern Lab Anim. 33:369–377. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lancaster MA and Knoblich JA:
Organogenesis in a dish: Modeling development and disease using
organoid technologies. Science. 345:12471252014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Clevers H: Modeling development and
disease with organoids. Cell. 165:1586–1597. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Method of the Year 2017, . Organoids. Nat
Methods. Jan 3–2018.(Epub ahead of print).
|
|
21
|
Jacob F, Salinas RD, Zhang DY, Nguyen PTT,
Schnoll JG, Wong SZH, Thokala R, Sheikh S, Saxena D, Prokop S, et
al: A patient-derived glioblastoma organoid model and biobank
recapitulates inter- and intra-tumoral heterogeneity. Cell.
180:188–204.e22. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sachs N, de Ligt J, Kopper O, Gogola E,
Bounova G, Weeber F, Balgobind AV, Wind K, Gracanin A, Begthel H,
et al: A living biobank of breast cancer organoids captures disease
heterogeneity. Cell. 172:373–386.e10. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Grassi L, Alfonsi R, Francescangeli F,
Signore M, De Angelis ML, Addario A, Costantini M, Flex E, Ciolfi
A, Pizzi S, et al: Organoids as a new model for improving
regenerative medicine and cancer personalized therapy in renal
diseases. Cell Death Dis. 10:2012019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vlachogiannis G, Hedayat S, Vatsiou A,
Jamin Y, Fernández-Mateos J, Khan K, Lampis A, Eason K, Huntingford
I, Burke R, et al: Patient-derived organoids model treatment
response of metastatic gastrointestinal cancers. Science.
359:920–926. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hofbauer P, Jahnel SM, Papai N,
Giesshammer M, Deyett A, Schmidt C, Penc M, Tavernini K, Grdseloff
N, Meledeth C, et al: Cardioids reveal self-organizing principles
of human cardiogenesis. Cell. 184:3299–3317.e22. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sheridan MA, Zhao X, Fernando RC, Gardner
L, Perez-Garcia V, Li Q, Marsh SGE, Hamilton R, Moffett A and Turco
MY: Characterization of primary models of human trophoblast.
Development. 148:dev1997492021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Khan AO, Rodriguez-Romera A, Reyat JS,
Olijnik AA, Colombo M, Wang G, Wen WX, Sousos N, Murphy LC,
Grygielska B, et al: Human bone marrow organoids for disease
modeling, discovery, and validation of therapeutic targets in
hematologic malignancies. Cancer Discov. 13:364–385. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bouffi C, Wikenheiser-Brokamp KA,
Chaturvedi P, Sundaram N, Goddard GR, Wunderlich M, Brown NE, Staab
JF, Latanich R, Zachos NC, et al: In vivo development of immune
tissue in human intestinal organoids transplanted into humanized
mice. Nat Biotechnol. 41:824–831. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Broutier L, Mastrogiovanni G, Verstegen
MM, Francies HE, Gavarró LM, Bradshaw CR, Allen GE, Arnes-Benito R,
Sidorova O, Gaspersz MP, et al: Human primary liver cancer-derived
organoid cultures for disease modeling and drug screening. Nat Med.
23:1424–1435. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sato T, Stange DE, Ferrante M, Vries RG,
Van Es JH, Van den Brink S, Van Houdt WJ, Pronk A, Van Gorp J,
Siersema PD and Clevers H: Long-term expansion of epithelial
organoids from human colon, adenoma, adenocarcinoma, and Barrett's
epithelium. Gastroenterology. 141:1762–1772. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ren W, Lewandowski BC, Watson J, Aihara E,
Iwatsuki K, Bachmanov AA, Margolskee RF and Jiang P: Single Lgr5-
or Lgr6-expressing taste stem/progenitor cells generate taste bud
cells ex vivo. Proc Natl Acad Sci USA. 111:16401–16406. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kessler M, Hoffmann K, Brinkmann V, Thieck
O, Jackisch S, Toelle B, Berger H, Mollenkopf HJ, Mangler M,
Sehouli J, et al: The Notch and Wnt pathways regulate stemness and
differentiation in human fallopian tube organoids. Nat Commun.
6:89892015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Turco MY, Gardner L, Hughes J,
Cindrova-Davies T, Gomez MJ, Farrell L, Hollinshead M, Marsh SGE,
Brosens JJ, Critchley HO, et al: Long-term, hormone-responsive
organoid cultures of human endometrium in a chemically defined
medium. Nat Cell Biol. 19:568–577. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li X, Francies HE, Secrier M, Perner J,
Miremadi A, Galeano-Dalmau N, Barendt WJ, Letchford L, Leyden GM,
Goffin EK, et al: Organoid cultures recapitulate esophageal
adenocarcinoma heterogeneity providing a model for clonality
studies and precision therapeutics. Nat Commun. 9:29832018.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Blau HM and Daley GQ: Stem Cells in the
Treatment of Disease. N Engl J Med. 380:1748–1760. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kim SY, Kim SM, Lim S, Lee JY, Choi SJ,
Yang SD, Yun MR, Kim CG, Gu SR, Park C, et al: Modeling clinical
responses to targeted therapies by patient-derived organoids of
advanced lung adenocarcinoma. Clin Cancer Res. 27:4397–4409. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Saito Y, Muramatsu T, Kanai Y, Ojima H,
Sukeda A, Hiraoka N, Arai E, Sugiyama Y, Matsuzaki J, Uchida R, et
al: Establishment of patient-derived organoids and drug screening
for biliary tract carcinoma. Cell Rep. 27:1265–1276.e4. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang XW, Xia TL, Tang HC, Liu X, Han R,
Zou X, Zhao YT, Chen MY and Li G: Establishment of a
patient-derived organoid model and living biobank for
nasopharyngeal carcinoma. Ann Transl Med. 10:5262022. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li J, Xu H, Zhang L, Song L, Feng D, Peng
X, Wu M, Zou Y, Wang B, Zhan L, et al: Malignant ascites-derived
organoid (MADO) cultures for gastric cancer in vitro modelling and
drug screening. J Cancer Res Clin Oncol. 145:2637–2647. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yuki K, Cheng N, Nakano M and Kuo CJ:
Organoid models of tumor immunology. Trends Immunol. 41:652–664.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lo YH, Karlsson K and Kuo CJ: Applications
of organoids for cancer biology and precision medicine. Nat Cancer.
1:761–773. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Joo H, Min S and Cho SW: Advanced lung
organoids for respiratory system and pulmonary disease modeling. J
Tissue Eng. 15:204173142412325022024. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yuan J, Li X and Yu S: Cancer organoid
co-culture model system: Novel approach to guide precision
medicine. Front Immunol. 13:10613882023. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Licata JP, Schwab KH, Har-El YE,
Gerstenhaber JA and Lelkes PI: Bioreactor technologies for enhanced
organoid culture. Int J Mol Sci. 24:114272023. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Park SE, Georgescu A and Huh D:
Organoids-on-a-chip. Science. 364:960–965. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Weeber F, van de Wetering M, Hoogstraat M,
Dijkstra KK, Krijgsman O, Kuilman T, Gadellaa-van Hooijdonk CG, van
der Velden DL, Peeper DS, Cuppen EP, et al: Preserved genetic
diversity in organoids cultured from biopsies of human colorectal
cancer metastases. Proc Natl Acad Sci USA. 112:13308–13311. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
O'Rourke KP, Loizou E, Livshits G,
Schatoff EM, Baslan T, Manchado E, Simon J, Romesser PB, Leach B,
Han T, et al: Transplantation of engineered organoids enables rapid
generation of metastatic mouse models of colorectal cancer. Nat
Biotechnol. 35:577–582. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Martin ML, Adileh M, Hsu KS, Hua G, Lee
SG, Li C, Fuller JD, Rotolo JA, Bodo S, Klingler S, et al:
Organoids reveal that inherent radiosensitivity of small and large
intestinal stem cells determines organ in review sensitivity.
Cancer Res. 80:1219–1227. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Sato T, Vries RG, Snippert HJ, van de
Wetering M, Barker N, Stange DE, van Es JH, Abo A, Kujala P, Peters
PJ and Clevers H: Single Lgr5 stem cells build crypt-villus
structures in vitro without a mesenchymal niche. Nature.
459:262–265. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Sato T and Clevers H: Growing
self-organizing mini-guts from a single intestinal stem cell:
Mechanism and applications. Science. 340:1190–1194. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Fujimichi Y, Otsuka K, Tomita M and
Iwasaki T: An efficient intestinal organoid system of direct
sorting to evaluate stem cell competition in vitro. Sci Rep.
9:202972019. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Lindemans CA, Calafiore M, Mertelsmann AM,
O'Connor MH, Dudakov JA, Jenq RR, Velardi E, Young LF, Smith OM,
Lawrence G, et al: Interleukin-22 promotes
intestinal-stem-cell-mediated epithelial regeneration. Nature.
528:560–564. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Qu M, Xiong L, Lyu Y, Zhang X, Shen J,
Guan J, Chai P, Lin Z, Nie B, Li C, et al: Establishment of
intestinal organoid cultures modeling injury-associated epithelial
regeneration. Cell Res. 31:259–271. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Gregorieff A, Liu Y, Inanlou MR, Khomchuk
Y and Wrana JL: Yap-dependent reprogramming of Lgr5(+) stem cells
drives intestinal regeneration and cancer. Nature. 526:715–718.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Farin HF, Van Es JH and Clevers H:
Redundant sources of wnt regulate intestinal stem cells and promote
formation of paneth cells. Gastroenterology. 143:1518–1529.e7.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Bhanja P, Saha S, Kabarriti R, Liu L,
Roy-Chowdhury N, Roy-Chowdhury J, Sellers RS, Alfieri AA and Guha
C: Protective role of R-spondin1, an intestinal stem cell growth
factor, against radiation-induced gastrointestinal syndrome in
mice. PLoS One. 4:e80142009. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Otsuka K, Hamada N, Magae J, Matsumoto H,
Hoshi Y and Iwasaki T: Ionizing radiation leads to the replacement
and de novo production of colonic Lgr5(+) stem cells. Radiat Res.
179:637–646. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Ganesh K, Wu C, O'Rourke KP, Szeglin BC,
Zheng Y, Sauvé CG, Adileh M, Wasserman I, Marco MR, Kim AS, et al:
A rectal cancer organoid platform to study individual responses to
chemoradiation. Nat Med. 25:1607–1614. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Yao Y, Xu X, Yang L, Zhu J, Wan J, Shen L,
Xia F, Fu G, Deng Y, Pan M, et al: Patient-Derived organoids
predict chemoradiation responses of locally advanced rectal cancer.
Cell Stem Cell. 26:17–26.e6. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Al Bitar S, Ballout F, Monzer A, Kanso M,
Saheb N, Mukherji D, Faraj W, Tawil A, Doughan S, Hussein M, et al:
Thymoquinone radiosensitizes human colorectal cancer cells in 2D
and 3D culture models. Cancers (Basel). 14:13632022. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Otsuka K, Suzuki K, Fujimichi Y, Tomita M
and Iwasaki T: Cellular responses and gene expression profiles of
colonic Lgr5+ stem cells after low-dose/low-dose-rate radiation
exposure. J Radiat Res. 59 (Suppl 2):ii18–ii22. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Schwartz DM, Pehlivaner Kara MO, Goldstein
AM, Ott HC and Ekenseair AK: Spray delivery of intestinal organoids
to reconstitute epithelium on decellularized native extracellular
matrix. Tissue Eng Part C Methods. 23:565–573. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Jee J, Park JH, Im JH, Kim MS, Park E, Lim
T, Choi WH, Kim JH, Kim WR, Ko JS, et al: Functional recovery by
colon organoid transplantation in a mouse model of radiation
proctitis. Biomaterials. 275:1209252021. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Lucky SS, Law M, Lui MH, Mong J, Shi J, Yu
S, Yoon DK, Djeng SK, Wang J, Lim CM and Tan MH: Patient-derived
nasopharyngeal cancer organoids for disease modeling and radiation
dose optimization. Front Oncol. 11:6222442021. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Driehuis E, Kolders S, Spelier S,
Lõhmussaar K, Willems SM, Devriese LA, de Bree R, de Ruiter EJ,
Korving J, Begthel H, et al: Oral mucosal organoids as a potential
platform for personalized cancer therapy. Cancer Discov. 9:852–871.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Karakasheva TA, Kijima T, Shimonosono M,
Maekawa H, Sahu V, Gabre JT, Cruz-Acuña R, Giroux V, Sangwan V,
Whelan KA, et al: Generation and characterization of
patient-derived head and neck, oral, and esophageal cancer
organoids. Curr Protoc Stem Cell Biol. 53:e1092020. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Hacker BC, Gomez JD, Batista CAS and Rafat
M: Growth and characterization of irradiated organoids from mammary
glands. J Vis Exp. May 3–2019.(Epub ahead of print). doi:
10.3791/59293. View
Article : Google Scholar
|
|
68
|
Hubert CG, Rivera M, Spangler LC, Wu Q,
Mack SC, Prager BC, Couce M, McLendon RE, Sloan AE and Rich JN: A
three-dimensional organoid culture system derived from human
glioblastomas recapitulates the hypoxic gradients and cancer stem
cell heterogeneity of tumors found in vivo. Cancer Res.
76:2465–2477. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Lumniczky K, Candéias SM, Gaipl US and
Frey B: Editorial: Radiation and the immune system: Current
knowledge and future perspectives. Front Immunol. 8:19332018.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Vanpouille-Box C, Alard A, Aryankalayil
MJ, Sarfraz Y, Diamond JM, Schneider RJ, Inghirami G, Coleman CN,
Formenti SC and Demaria S: DNA exonuclease Trex1 regulates
radiotherapy-induced tumour immunogenicity. Nat Commun.
8:156182017. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Park HJ, Griffin RJ, Hui S, Levitt SH and
Song CW: Radiation-induced vascular damage in tumors: Implications
of vascular damage in ablative hypofractionated radiotherapy (SBRT
and SRS). Radiat Res. 77:311–327. 2012. View Article : Google Scholar
|
|
72
|
Zhang Z, Liu X, Chen D and Yu J:
Radiotherapy combined with immunotherapy: The dawn of cancer
treatment. Signal Transduct Target Ther. 7:2582022. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Gong W, Guo M, Han Z, Wang Y, Yang P, Xu
C, Wang Q, Du L, Li Q, Zhao H, et al: Mesenchymal stem cells
stimulate intestinal stem cells to repair radiation-induced
intestinal injury. Cell Death Dis. 7:e23872016. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Chiang CS, Fu SY, Wang SC, Yu CF, Chen FH,
Lin CM and Hong JH: Irradiation promotes an m2 macrophage phenotype
in tumor hypoxia. Front Oncol. 2:892012. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Moussa L, Lapière A, Squiban C, Demarquay
C, Milliat F and Mathieu N: BMP antagonists secreted by mesenchymal
stromal cells improve colonic organoid formation: Application for
the treatment of radiation-induced injury. Cell Transplant.
29:9636897209296832020. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Gao B and Xiang X: Interleukin-22 from
bench to bedside: A promising drug for epithelial repair. Cell Mol
Immunol. 16:666–667. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Aiyappa-Maudsley R, Chalmers AJ and
Parsons JL: Factors affecting the radiation response in
glioblastoma. Neurooncol Adv. 4:vdac1562022.PubMed/NCBI
|
|
78
|
Kim YH, Han SH, Kim H, Lee SJ, Joo HW, Kim
MJ, Shim S, Kim K, Lee J, Jang WS, et al: Evaluation of the
radiation response and regenerative effects of mesenchymal stem
cell-conditioned medium in an intestinal organoid system.
Biotechnol Bioeng. 117:3639–3650. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Perumal V, Corica T, Dharmarajan AM, Sun
Z, Dhaliwal SS, Dass CR and Dass J: Circulating tumour cells (CTC),
head and neck cancer and radiotherapy; Future. Perspectives.
Cancers (Basel). 11:3672019. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Chen CC, Li HW, Wang YL, Lee CC, Shen YC,
Hsieh CY, Lin HL, Chen XX, Cho DY, Hsieh CL, et al: Patient-derived
tumor organoids as a platform of precision treatment for malignant
brain tumors. Sci Rep. 12:163992022. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Peng X, Wu Y, Brouwer U, van Vliet T, Wang
B, Demaria M, Barazzuol L and Coppes RP: Cellular senescence
contributes to radiation-induced hyposalivation by affecting the
stem/progenitor cell niche. Cell Death Dis. 11:8542020. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Seol HS, Oh JH, Choi E, Kim S, Kim H and
Nam EJ: Preclinical investigation of patient-derived cervical
cancer organoids for precision medicine. J Gynecol Oncol.
34:e352023. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Lenti E, Bianchessi S, Proulx ST, Palano
MT, Genovese L, Raccosta L, Spinelli A, Drago D, Andolfo A, Alfano
M, et al: Therapeutic regeneration of lymphatic and immune cell
functions upon lympho-organoid transplantation. Stem Cell Reports.
12:1260–1268. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Ding RB, Chen P, Rajendran BK, Lyu X, Wang
H, Bao J, Zeng J, Hao W, Sun H, Wong AH, et al: Molecular landscape
and subtype-specific therapeutic response of nasopharyngeal
carcinoma revealed by integrative pharmacogenomics. Nat Commun.
12:30462021. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Li W, Zhang XJ, Feng XY, Chen D, Luo JQ
and Zhu BJ: Three-dimensional culture and characterization of
patient-derived nasopharyngeal carcinoma organoids. Res Sq. Oct
13–2020.(Epub ahead of print). doi: 10.21203/rs.3.rs-90861/v1.
|
|
87
|
Yip YL, Lin WT, Deng W, Tsang CM and Tsao
SW: Establishment of nasopharyngeal carcinoma cell lines,
patient-derived xenografts, and immortalized nasopharyngeal
epithelial cell lines for nasopharyngeal carcinoma and epstein-barr
virus infection studies. Nasopharyngeal Carcinoma. Lee AWM, Lung ML
and Ng WT: Elsevier; Amsterdam: 2019, View Article : Google Scholar
|
|
88
|
Rycaj K and Tang DG: Cancer stem cells and
radioresistance. Int J Radiat Biol. 90:615–621. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Hill SJ, Decker B, Roberts EA, Horowitz
NS, Muto MG, Worley MJ Jr, Feltmate CM, Nucci MR, Swisher EM,
Nguyen H, et al: Prediction of DNA repair inhibitor response in
short-term patient-derived ovarian cancer organoids. Cancer Discov.
8:1404–1421. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Lai X, Li Q, Wu F, Lin J, Chen J, Zheng H
and Guo L: Epithelial-mesenchymal transition and metabolic
switching in cancer: Lessons from somatic cell reprogramming. Front
Cell Dev Biol. 8:7602020. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Populin L, Stebbing MJ and Furness JB:
Neuronal regulation of the gut immune system and neuromodulation
for treating inflammatory bowel disease. FASEB Bioadv. 3:953–966.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Takahashi T: Organoids for drug discovery
and personalized medicine. Annu Rev Pharmacol Toxicol. 59:447–462.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Foo MA, You M, Chan SL, Sethi G, Bonney
GK, Yong WP, Chow EK, Fong ELS, Wang L and Goh BC: Clinical
translation of patient-derived tumour organoids-bottlenecks and
strategies. Biomark Res. 10:102022. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Mollica PA, Booth-Creech EN, Reid JA,
Zamponi M, Sullivan SM, Palmer XL, Sachs PC and Bruno RD: 3D
bioprinted mammary organoids and tumoroids in human mammary derived
ECM hydrogels. Acta Biomater. 95:201–213. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Conlon GA and Murray GI: Recent advances
in understanding the roles of matrix metalloproteinases in tumour
invasion and metastasis. J Pathol. 247:629–640. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Long L, Yin M and Min W: 3D Co-culture
system of tumor-associated macrophages and ovarian cancer cells.
Bio Protoc. 8:e28152018. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Schaue D, Xie MW, Ratikan JA and McBride
WH: Regulatory T cells in radiotherapeutic responses. Front Oncol.
2:902012. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Pulze L, Congiu T, Brevini TAL, Grimaldi
A, Tettamanti G, D'Antona P, Baranzini N, Acquati F, Ferraro F and
de Eguileor M: MCF7 spheroid development: New insight about
spatio/temporal arrangements of TNTs, Amyloid Fibrils, Cell
Connections, and Cellular Bridges. Int J Mol Sci. 21:54002020.
View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Kroll KT, Mata MM, Homan KA, Micallef V,
Carpy A, Hiratsuka K, Morizane R, Moisan A, Gubler M, Walz AC, et
al: Immune-infiltrated kidney organoid-on-chip model for assessing
T cell bispecific antibodies. Proc Natl Acad Sci USA.
120:e23053221202023. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Fabi A, Bhargava R, Fatigoni S, Guglielmo
M, Horneber M, Roila F, Weis J, Jordan K and Ripamonti CI; ESMO
Guidelines Committee. Electronic address, : simpleclinicalguidelines@esmo.org:
Cancer-related fatigue: ESMO Clinical Practice Guidelines for
diagnosis and treatment. Ann Oncol. 31:713–723. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Baskar R, Yap SP, Chua KL and Itahana K:
The diverse and complex roles of radiation on cancer treatment:
Therapeutic target and genome maintenance. Am J Cancer Res.
2:372–382. 2012.PubMed/NCBI
|
|
102
|
Lin B, Gao F, Yang Y, Wu D, Zhang Y, Feng
G, Dai T and Du X: FLASH radiotherapy: History and future. Front
Oncol. 11:6444002021. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Hafeez U, Parakh S, Gan HK and Scott AM:
Antibody-drug conjugates for cancer therapy. Molecules.
25:47642020. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Lv J, Du X, Wang M, Su J, Wei Y and Xu C:
Construction of tumor organoids and their application to cancer
research and therapy. Theranostics. 14:1101–1125. 2021. View Article : Google Scholar : PubMed/NCBI
|
